This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Afinitor
  • /
  • A Study of E7080 Alone, and in Combination With Ev...
Clinical trial

A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment

Read time: 1 mins
Last updated:1st Aug 2010
Register free for full access to medthority.com